These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27212563)

  • 1. Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation.
    Verleden SE; Ruttens D; Vandermeulen E; Bellon H; Dubbeldam A; De Wever W; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM; Benden C; Vos R
    J Heart Lung Transplant; 2016 Sep; 35(9):1078-84. PubMed ID: 27212563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
    Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
    Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restrictive chronic lung allograft dysfunction: Where are we now?
    Verleden SE; Ruttens D; Vandermeulen E; Bellon H; Van Raemdonck DE; Dupont LJ; Vanaudenaerde BM; Verleden G; Vos R
    J Heart Lung Transplant; 2015 May; 34(5):625-30. PubMed ID: 25577564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
    Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM
    Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study.
    Verleden SE; Todd JL; Sato M; Palmer SM; Martinu T; Pavlisko EN; Vos R; Neyrinck A; Van Raemdonck D; Saito T; Oishi H; Keshavjee S; Greer M; Warnecke G; Gottlieb J; Haverich A
    Am J Transplant; 2015 Aug; 15(8):2223-30. PubMed ID: 25940517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation.
    Verleden SE; Ruttens D; Vandermeulen E; van Raemdonck DE; Vanaudenaerde BM; Verleden GM; Vos R
    Transplantation; 2014 Jan; 97(1):83-9. PubMed ID: 24157472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lung allograft dysfunction phenotypes and treatment.
    Verleden SE; Vos R; Vanaudenaerde BM; Verleden GM
    J Thorac Dis; 2017 Aug; 9(8):2650-2659. PubMed ID: 28932572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
    Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
    Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
    J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
    Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
    Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation.
    Matsubara K; Otani S; Yamamoto H; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
    Surg Today; 2024 Apr; 54(4):317-324. PubMed ID: 37523071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Resolution CT Findings of Obstructive and Restrictive Phenotypes of Chronic Lung Allograft Dysfunction: More Than Just Bronchiolitis Obliterans Syndrome.
    Hota P; Dass C; Kumaran M; Simpson S
    AJR Am J Roentgenol; 2018 Jul; 211(1):W13-W21. PubMed ID: 29792746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "White-Out" After Lung Transplantation: A Multicenter Cohort Description of Late Acute Graft Failure.
    Verleden SE; Gottlieb J; Dubbeldam A; Verleden GM; Suhling H; Welte T; Vos R; Greer M
    Am J Transplant; 2017 Jul; 17(7):1905-1911. PubMed ID: 28296181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histomorphological spectrum of restrictive chronic lung allograft dysfunction and implications for prognosis.
    von der Thüsen JH; Vandermeulen E; Vos R; Weynand B; Verbeken EK; Verleden SE
    Mod Pathol; 2018 May; 31(5):780-790. PubMed ID: 29327719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
    Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic lung allograft dysfunction after lung transplantation: the moving target.
    Sato M
    Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
    Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
    Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.